CFDE Data Portal | Search NUDT16L2P

	Label	Description
	NUDT16L2P Gene (Entity type)	ENSG00000293492 - nudix hydrolase 16 like 2, pseudogene
	GSE114492 GSE153671 KMT2D inhibition 6 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE146982 metformin 4 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE196343 metformin 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE196035 GSE196037 MEN1 inhibition 6 v 10 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE80098 GSE80366 progesterone 0 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE77108 saha 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE108464 AZ-628 6 v 10 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE233679 nicotinamide 14 v 15 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 sulforaphane 2 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS

NUDT16L2P

ENSG00000293492 - nudix hydrolase 16 like 2, pseudogene

GSE114492 GSE153671 KMT2D inhibition 6 v 8 human dn

A Gene Set from LINCS

GSE146982 metformin 4 v 2 human up

A Gene Set from LINCS

GSE196343 metformin 1 v 0 human dn

A Gene Set from LINCS

GSE196035 GSE196037 MEN1 inhibition 6 v 10 human up

A Gene Set from LINCS

GSE80098 GSE80366 progesterone 0 v 5 human dn

A Gene Set from LINCS

GSE77108 saha 0 v 1 human dn

A Gene Set from LINCS

GSE108464 AZ-628 6 v 10 human up

A Gene Set from LINCS

GSE233679 nicotinamide 14 v 15 human up

A Gene Set from LINCS

GSE48812 sulforaphane 2 v 10 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.